Abstract
Reopening of universities in the U.S. has been controversial in the setting of the coronavirus disease 2019 (COVID-19) pandemic. We leveraged several publicly available data sources to study the association of county-level new confirmed COVID-19 case rates since September 1st and the number of students returning to campus across 2,893 U.S. counties with and without universities. In 1,069 U.S. counties with universities, we also studied the association of different reopening policies (online, in-person, hybrid) on new confirmed COVID-19 cases. Multivariate regression models estimated both effects of university reopening and different reopening policies. Mean number of daily confirmed cases per 10,000 county population was 1.51 from August 1st to August 31st, and 1.98 from September 1st to October 22nd. Mean number of students returning to universities was 2.1% (95% CI, 1.8% to 2.3%) of the county population and the number of students returning to campus had a positive association (β = 2.006, p-value < 0.001) with new confirmed COVID-19 cases within the local county region where the institution resided. For U.S. counties with universities, the mean proportion of online enrollment within each county was 40.1% (95% CI, 37.4% to 42.8%), with most students enrolling in-person or hybrid mode. In comparison to holding class in-person, reopening universities online (β = -0.329, p-value < 0.001) or in a hybrid mode (β = -0.272, p-value = 0.012) was negatively associated with new confirmed COVID-19 cases. These findings could help public health officials consider policies to mitigate additional waves of infection during the upcoming winter.
Significance Statement Our study finds that higher numbers of students returning to campus was associated with an increase in new confirmed COVID-19 cases; reopening online or partially online was associated with slower spread of the virus, in comparison to in-person reopening. These findings could provide guidance for policymakers on universities’ reopening in upcoming semesters.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was provided to support this manuscript. This work was done through support and access to the American Heart Association COVID-19 Data Challenge Award and its Precision Medicine Platform. Our team was awarded the final prize as part of this competition.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing Interest Statement: The authors have declared that no competing interest exist.
Data Availability
All datasets used are publicly available. Our analysis was conducted using R statistical software version 3.6.0 and 3.6.1. All statistical code is available for replication at https://github.com/yli15/COVID-19-research.
